| NCT ID | NCT04099641 |
| Title | An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Oncologie Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |